<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="6.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Mehta, Michael D.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">From biotechnology to nanotechnology : What can we learn from earlier technologies?</style></title><secondary-title><style face="normal" font="default" size="100%">Bulletin of Science, Technology &amp; Society</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2004</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2004</style></date></pub-dates></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://www.nanoandsociety.org/ourlibrary/documents/mehta-feb2004a.pdf</style></url></web-urls></urls><publisher><style face="normal" font="default" size="100%">Sage Publications</style></publisher><volume><style face="normal" font="default" size="100%">24</style></volume><pages><style face="normal" font="default" size="100%">34-39</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">Using Canada as a case study, this article argues the main problem with regulations developed for biotechnology was the absence of public engagement. The author argues that future regulators of nanotechnology should learn from this mistake and consult the public early and often as a regulatory framework is developed for this potentially transformative technology.</style></abstract><issue><style face="normal" font="default" size="100%">1</style></issue><work-type><style face="normal" font="default" size="100%">Journal Article</style></work-type></record></records></xml>